US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nurix Therapeutics

22.02

-0.7100-3.12%

Volume:830.69K

Turnover:18.14M

Market Cap:2.28B

PE:-6.46

High:22.60

Open:22.49

Low:21.55

Close:22.73

52wk High:28.23

52wk Low:9.00

Shares:103.41M

Float Shares:74.11M

Volume Ratio:1.31

T/O Rate:1.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4102

EPS(LYR):-3.0514

ROE:-80.30%

ROA:-40.06%

PB:5.66

PE(LYR):-7.22

Loading ...

Overview Company News Filings

U.S. Earnings Preview: After Market Close Oct. 7

Nurix Enrolls First Patient in Phase 1b/2 CLL Trial of BTK Degrader Bexobrutideg Plus Venetoclax

Nurix Therapeutics Announces First Patient Enrolled in Phase 1B/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

THOMSON REUTERS

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Nurix Extends Gilead Collaboration for Oncology Program

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

THOMSON REUTERS

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS

Nurix Therapeutics Chief Legal Officer Christine Ring Reports Common Share Disposal Worth $134,160.79

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

THOMSON REUTERS

Nurix CSO Gwenn Hansen Disposes of 1,452 Common Shares Worth $36,982.44

Nurix Therapeutics to Participate in Upcoming September Investor Conferences

Nurix Advances NX-5948 Combo Trial in B-Cell Cancers, Setting Up Key Catalyst for NRIX

BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says

MT Newswires Live

Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer

THOMSON REUTERS

Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right?

Simply Wall St.

Nurix Therapeutics (NRIX) Is Up 6.0% After Milestone From Sanofi And Phase 3 Start With Roche

Simply Wall St.

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/NRIX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NRIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRIX\",,,,,undefined,":{"symbol":"NRIX","market":"US","secType":"STK","nameCN":"Nurix Therapeutics","latestPrice":22.02,"timestamp":1791478662522,"preClose":22.73,"halted":0,"volume":830694,"delay":0,"changeRate":-0.03123625164980206,"floatShares":74111900,"shares":103405813,"eps":-3.410201,"marketStatus":"Trading","change":-0.71,"latestTime":"10-08 12:57:45 EDT","open":22.49,"high":22.6,"low":21.55,"amount":18143142.796524,"amplitude":0.046194,"askPrice":22.07,"askSize":200,"bidPrice":22.04,"bidSize":278,"shortable":3,"etf":0,"ttmEps":-3.410201,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":22.73,"preHourTrading":{"tag":"盘前","latestPrice":22.43,"preClose":22.73,"latestTime":"09:29 EDT","volume":1280,"amount":28914.944,"timestamp":1791466199999,"change":-0.3,"changeRate":-0.013198,"amplitude":0.051087},"postHourTrading":{"tag":"盘后","latestPrice":22.73,"preClose":22.73,"latestTime":"19:30 EDT","volume":273028,"amount":6205924.16,"timestamp":1791415802954,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.31042,"impliedVol":0.6369,"impliedVolPercentile":0.3944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRIX\",,,,,undefined,":{"symbol":"NRIX","floatShares":74111900,"roa":"-40.06%","roe":"-80.30%","lyrEps":-3.051418,"volumeRatio":1.31042,"shares":103405813,"dividePrice":0,"high":22.6,"amplitude":0.046194,"preClose":22.73,"low":21.55,"week52Low":9,"pbRate":"5.66","psRate":"61.93","week52High":28.23,"institutionHeld":0,"latestPrice":22.02,"committee":0.16318,"eps":-3.410201,"divideRate":0,"volume":830694,"delay":0,"ttmEps":-3.410201,"open":22.49,"prevYearClose":18.97,"prevWeekClose":22.99,"prevMonthClose":23.71,"prevQuarterClose":23.71,"fiveDayClose":23.34,"twentyDayClose":25.81,"sixtyDayClose":23.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-09","symbol":"NRIX","fiscalQuarterEnding":"2026/05","expectedEps":-0.73,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1783569600000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2026-04-08","symbol":"NRIX","fiscalQuarterEnding":"2026/02","expectedEps":-0.76,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1775620800000,"reportTimeType":"pre","actualEps":-0.79},{"date":"2026-01-28","symbol":"NRIX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769634000000,"name":null,"time":"Post-Mkt","dateTimestamp":1769576400000,"actualEps":null},{"market":"US","date":"2025-10-09","symbol":"NRIX","fiscalQuarterEnding":"2025/08","expectedEps":-0.84,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1759982400000,"reportTimeType":"post","actualEps":-1.03},{"market":"US","date":"2025-07-09","symbol":"NRIX","fiscalQuarterEnding":"2025/05","expectedEps":-0.71,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1752033600000,"reportTimeType":"post","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3571,"buy":0.5714,"hold":0.0714,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":14,"updateTime":1780977600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRIX","date":"2026-10-07","current":-6.465895,"percent":0.298132,"low":-15.483334,"twenty":-7.93554,"median":-5.005311,"eighty":-3.066718,"high":-1.435129,"avg":-5.633435,"sd":2.899777,"marketCap":2345466035},"quantilePoints":[{"date":"2021-10-08","current":-13.743761,"twenty":-44.117739,"median":-29.610086,"eighty":-17.952663,"marketCap":1224404151},{"date":"2021-10-15","current":-12.938682,"twenty":-43.730361,"median":-29.233053,"eighty":-17.668412,"marketCap":1286182613},{"date":"2021-10-22","current":-12.588624,"twenty":-43.528918,"median":-28.787346,"eighty":-17.308361,"marketCap":1251384748},{"date":"2021-10-29","current":-15.012102,"twenty":-43.390876,"median":-28.448284,"eighty":-16.700963,"marketCap":1492293042},{"date":"2021-11-05","current":-15.258938,"twenty":-43.173648,"median":-28.037639,"eighty":-16.366844,"marketCap":1516829998},{"date":"2021-11-12","current":-15.285866,"twenty":-42.883876,"median":-27.98663,"eighty":-16.040704,"marketCap":1519506756},{"date":"2021-11-19","current":-14.065151,"twenty":-42.564996,"median":-27.691781,"eighty":-15.874144,"marketCap":1398160356},{"date":"2021-11-26","current":-13.490696,"twenty":-42.483999,"median":-27.43862,"eighty":-15.694616,"marketCap":1341056168},{"date":"2021-12-03","current":-12.130856,"twenty":-42.416511,"median":-27.118823,"eighty":-15.489486,"marketCap":1205879848},{"date":"2021-12-10","current":-12.817508,"twenty":-42.340661,"median":-26.905637,"eighty":-15.364487,"marketCap":1274137198},{"date":"2021-12-17","current":-12.68287,"twenty":-42.246548,"median":-26.61577,"eighty":-15.315616,"marketCap":1260753404},{"date":"2021-12-23","current":-13.697141,"twenty":-42.003875,"median":-26.468139,"eighty":-15.285866,"marketCap":1361577986},{"date":"2021-12-31","current":-12.992537,"twenty":-41.885039,"median":-26.220076,"eighty":-15.258938,"marketCap":1291536130},{"date":"2022-01-07","current":-12.413595,"twenty":-41.779588,"median":-25.687803,"eighty":-15.182643,"marketCap":1233985816},{"date":"2022-01-14","current":-10.429933,"twenty":-41.754064,"median":-25.276578,"eighty":-15.030368,"marketCap":1036797916},{"date":"2022-01-21","current":-8.576421,"twenty":-41.512966,"median":-24.914563,"eighty":-15.007614,"marketCap":852547684},{"date":"2022-01-28","current":-6.741548,"twenty":-41.393639,"median":-24.632998,"eighty":-14.872977,"marketCap":790068982},{"date":"2022-02-04","current":-6.947688,"twenty":-41.151102,"median":-24.250872,"eighty":-14.737142,"marketCap":814227377},{"date":"2022-02-11","current":-6.711009,"twenty":-41.051087,"median":-24.085956,"eighty":-14.377091,"marketCap":786489961},{"date":"2022-02-18","current":-6.03151,"twenty":-41.028992,"median":-23.832546,"eighty":-14.101054,"marketCap":706856734},{"date":"2022-02-25","current":-6.073501,"twenty":-40.972053,"median":-23.780255,"eighty":-13.87217,"marketCap":711777888},{"date":"2022-03-04","current":-5.241305,"twenty":-40.912935,"median":-23.683718,"eighty":-13.606485,"marketCap":614249554},{"date":"2022-03-11","current":-5.252758,"twenty":-40.895309,"median":-23.643495,"eighty":-13.42607,"marketCap":615591687},{"date":"2022-03-18","current":-5.565785,"twenty":-40.849513,"median":-23.506734,"eighty":-13.123967,"marketCap":652276657},{"date":"2022-03-25","current":-5.323828,"twenty":-40.76937,"median":-23.285503,"eighty":-12.977278,"marketCap":623920753},{"date":"2022-04-01","current":-5.339138,"twenty":-40.691336,"median":-22.991871,"eighty":-12.936887,"marketCap":625714918},{"date":"2022-04-08","current":-4.918066,"twenty":-40.453018,"median":-22.384493,"eighty":-12.779809,"marketCap":666161875},{"date":"2022-04-14","current":-4.54639,"twenty":-40.267425,"median":-22.114994,"eighty":-12.717876,"marketCap":615817657},{"date":"2022-04-22","current":-4.164759,"twenty":-40.120852,"median":-21.672533,"eighty":-12.645172,"marketCap":564124934},{"date":"2022-04-29","current":-3.673616,"twenty":-39.947388,"median":-21.294431,"eighty":-12.566184,"marketCap":497598647},{"date":"2022-05-06","current":-3.172518,"twenty":-39.792896,"median":-21.053088,"eighty":-12.38936,"marketCap":429723854},{"date":"2022-05-13","current":-3.179155,"twenty":-39.645265,"median":-20.827835,"eighty":-11.806013,"marketCap":430622858},{"date":"2022-05-20","current":-3.311896,"twenty":-39.55036,"median":-20.66694,"eighty":-10.865261,"marketCap":448602936},{"date":"2022-05-27","current":-2.993317,"twenty":-39.465999,"median":-20.349173,"eighty":-10.415195,"marketCap":405450749},{"date":"2022-06-03","current":-3.507689,"twenty":-39.364993,"median":-19.942914,"eighty":-8.82954,"marketCap":475123550},{"date":"2022-06-10","current":-3.358355,"twenty":-39.064084,"median":-19.476319,"eighty":-8.497433,"marketCap":454895963},{"date":"2022-06-17","current":-3.690209,"twenty":-38.354548,"median":-19.267156,"eighty":-7.256135,"marketCap":499846157},{"date":"2022-06-24","current":-4.204581,"twenty":-38.320804,"median":-18.673351,"eighty":-7.10802,"marketCap":569518957},{"date":"2022-07-01","current":-4.420286,"twenty":-38.265652,"median":-17.952663,"eighty":-6.733913,"marketCap":598736584},{"date":"2022-07-08","current":-5.39332,"twenty":-38.12418,"median":-17.852926,"eighty":-6.517586,"marketCap":833111606},{"date":"2022-07-15","current":-5.033969,"twenty":-37.996015,"median":-17.690853,"eighty":-6.131526,"marketCap":777602193},{"date":"2022-07-22","current":-4.817749,"twenty":-37.96438,"median":-17.424057,"eighty":-5.923095,"marketCap":744202462},{"date":"2022-07-29","current":-4.860384,"twenty":-37.641701,"median":-17.192168,"eighty":-5.690631,"marketCap":750788325},{"date":"2022-08-05","current":-5.901894,"twenty":-37.291604,"median":-16.760805,"eighty":-5.594034,"marketCap":911671537},{"date":"2022-08-12","current":-5.094876,"twenty":-36.98928,"median":-16.51645,"eighty":-5.581055,"marketCap":787010568},{"date":"2022-08-19","current":-4.753796,"twenty":-36.81114,"median":-16.35687,"eighty":-5.500216,"marketCap":734323668},{"date":"2022-08-26","current":-4.69898,"twenty":-36.691918,"median":-16.062646,"eighty":-5.391929,"marketCap":725856131},{"date":"2022-09-02","current":-4.881701,"twenty":-36.455195,"median":-15.987844,"eighty":-5.336076,"marketCap":754081256},{"date":"2022-09-09","current":-4.832975,"twenty":-36.180153,"median":-15.913041,"eighty":-5.274732,"marketCap":746554556},{"date":"2022-09-16","current":-4.73857,"twenty":-35.969349,"median":-15.745981,"eighty":-5.241204,"marketCap":731971575},{"date":"2022-09-23","current":-3.815828,"twenty":-35.840856,"median":-15.578922,"eighty":-5.1771,"marketCap":589434693},{"date":"2022-09-30","current":-3.968095,"twenty":-35.464759,"median":-15.498714,"eighty":-5.129711,"marketCap":612955631},{"date":"2022-10-07","current":-3.018537,"twenty":-35.207989,"median":-15.393576,"eighty":-5.038841,"marketCap":517211157},{"date":"2022-10-14","current":-2.99102,"twenty":-35.023324,"median":-15.357007,"eighty":-4.976716,"marketCap":512496379},{"date":"2022-10-21","current":-3.128602,"twenty":-34.771308,"median":-15.319606,"eighty":-4.938445,"marketCap":536070269},{"date":"2022-10-28","current":-3.53034,"twenty":-34.628148,"median":-15.302152,"eighty":-4.900583,"marketCap":604906030},{"date":"2022-11-04","current":-3.566111,"twenty":-34.512456,"median":-15.279711,"eighty":-4.868911,"marketCap":611035241},{"date":"2022-11-11","current":-4.014626,"twenty":-34.412754,"median":-15.258938,"eighty":-4.845766,"marketCap":687886124},{"date":"2022-11-18","current":-3.577117,"twenty":-34.361046,"median":-15.249962,"eighty":-4.812267,"marketCap":612921153},{"date":"2022-11-25","current":-3.263432,"twenty":-34.253984,"median":-15.182643,"eighty":-4.789322,"marketCap":559172682},{"date":"2022-12-02","current":-3.469804,"twenty":-34.059896,"median":-15.127612,"eighty":-4.722125,"marketCap":594533518},{"date":"2022-12-09","current":-3.282693,"twenty":-33.952835,"median":-15.025566,"eighty":-4.692889,"marketCap":562473027},{"date":"2022-12-16","current":-3.348732,"twenty":-33.90893,"median":-15.000882,"eighty":-4.580903,"marketCap":573788494},{"date":"2022-12-23","current":-2.856191,"twenty":-33.866191,"median":-14.922344,"eighty":-4.442852,"marketCap":489393966},{"date":"2022-12-30","current":-3.021288,"twenty":-33.818475,"median":-14.837073,"eighty":-4.382565,"marketCap":517682635},{"date":"2023-01-06","current":-3.015785,"twenty":-33.777967,"median":-14.77873,"eighty":-4.217856,"marketCap":516739679},{"date":"2023-01-13","current":-3.208399,"twenty":-33.702061,"median":-14.683782,"eighty":-4.196497,"marketCap":549743126},{"date":"2023-01-20","current":-3.491817,"twenty":-33.653895,"median":-14.446907,"eighty":-4.128919,"marketCap":598305340},{"date":"2023-01-27","current":-3.406516,"twenty":-33.368328,"median":-14.352156,"eighty":-4.010192,"marketCap":583689528},{"date":"2023-02-03","current":-3.445039,"twenty":-33.209045,"median":-14.087591,"eighty":-3.965659,"marketCap":590290218},{"date":"2023-02-10","current":-3.053513,"twenty":-33.160017,"median":-13.935001,"eighty":-3.919014,"marketCap":550731591},{"date":"2023-02-17","current":-2.547652,"twenty":-32.807783,"median":-13.720451,"eighty":-3.897949,"marketCap":459494512},{"date":"2023-02-24","current":-2.309137,"twenty":-32.658227,"median":-13.602895,"eighty":-3.855472,"marketCap":416475993},{"date":"2023-03-03","current":-2.377284,"twenty":-32.594539,"median":-13.490696,"eighty":-3.800691,"marketCap":428766998},{"date":"2023-03-10","current":-2.243611,"twenty":-32.579736,"median":-13.344839,"eighty":-3.741978,"marketCap":404657718},{"date":"2023-03-17","current":-2.361558,"twenty":-32.549134,"median":-13.149614,"eighty":-3.642714,"marketCap":425930612},{"date":"2023-03-24","current":-2.325443,"twenty":-32.528914,"median":-12.994781,"eighty":-3.58207,"marketCap":419416929},{"date":"2023-03-31","current":-2.335966,"twenty":-32.397695,"median":-12.961122,"eighty":-3.523935,"marketCap":421314743},{"date":"2023-04-06","current":-2.30966,"twenty":-32.202246,"median":-12.94317,"eighty":-3.504769,"marketCap":416570208},{"date":"2023-04-14","current":-2.691652,"twenty":-32.04029,"median":-12.936438,"eighty":-3.48081,"marketCap":480621436},{"date":"2023-04-21","current":-2.888278,"twenty":-31.878334,"median":-12.817508,"eighty":-3.469804,"marketCap":515730997},{"date":"2023-04-28","current":-2.55614,"twenty":-31.865332,"median":-12.763653,"eighty":-3.447373,"marketCap":456424305},{"date":"2023-05-05","current":-2.508312,"twenty":-31.812889,"median":-12.718774,"eighty":-3.428529,"marketCap":447884141},{"date":"2023-05-12","current":-2.704938,"twenty":-31.68378,"median":-12.664919,"eighty":-3.405415,"marketCap":482993703},{"date":"2023-05-19","current":-2.588025,"twenty":-31.522804,"median":-12.626771,"eighty":-3.394959,"marketCap":462117747},{"date":"2023-05-26","current":-2.585368,"twenty":-31.450335,"median":-12.566184,"eighty":-3.361663,"marketCap":461643294},{"date":"2023-06-01","current":-2.688995,"twenty":-31.383926,"median":-12.512329,"eighty":-3.356987,"marketCap":480146982},{"date":"2023-06-09","current":-2.880307,"twenty":-31.270013,"median":-12.413595,"eighty":-3.348533,"marketCap":514307637},{"date":"2023-06-16","current":-2.952049,"twenty":-31.073536,"median":-12.198175,"eighty":-3.328882,"marketCap":527117882},{"date":"2023-06-23","current":-2.707595,"twenty":-30.808492,"median":-11.815274,"eighty":-3.31376,"marketCap":483468157},{"date":"2023-06-30","current":-2.65711,"twenty":-30.665079,"median":-11.454796,"eighty":-3.301954,"marketCap":474453540},{"date":"2023-07-05","current":-2.673053,"twenty":-30.631463,"median":-11.175982,"eighty":-3.28641,"marketCap":477300261},{"date":"2023-07-13","current":-2.651796,"twenty":-30.517704,"median":-10.600474,"eighty":-3.272787,"marketCap":473504632},{"date":"2023-07-21","current":-2.962065,"twenty":-30.3277,"median":-10.429933,"eighty":-3.261231,"marketCap":466335686},{"date":"2023-07-28","current":-2.819702,"twenty":-30.147641,"median":-10.415195,"eighty":-3.239766,"marketCap":443922653},{"date":"2023-08-04","current":-2.844195,"twenty":-29.958421,"median":-8.865892,"eighty":-3.207321,"marketCap":447778659},{"date":"2023-08-11","current":-2.887057,"twenty":-29.871852,"median":-8.746962,"eighty":-3.177645,"marketCap":454526669},{"date":"2023-08-18","current":-2.614577,"twenty":-29.851356,"median":-8.394659,"eighty":-3.162187,"marketCap":411628606},{"date":"2023-08-25","current":-2.571715,"twenty":-29.563472,"median":-7.329429,"eighty":-3.113743,"marketCap":404880596},{"date":"2023-09-01","current":-2.602331,"twenty":-29.358973,"median":-7.18055,"eighty":-3.092962,"marketCap":409700603},{"date":"2023-09-08","current":-2.749286,"twenty":-29.301388,"median":-7.085115,"eighty":-3.067123,"marketCap":432836637},{"date":"2023-09-15","current":-2.718671,"twenty":-29.149148,"median":-6.741548,"eighty":-3.032295,"marketCap":428016630},{"date":"2023-09-22","current":-2.767656,"twenty":-28.988249,"median":-6.711009,"eighty":-3.021288,"marketCap":435728641},{"date":"2023-09-29","current":-2.492115,"twenty":-28.817014,"median":-6.260554,"eighty":-3.017343,"marketCap":392348577},{"date":"2023-10-06","current":-2.106357,"twenty":-28.588957,"median":-6.159393,"eighty":-3.010282,"marketCap":331616488},{"date":"2023-10-13","current":-2.032012,"twenty":-28.487644,"median":-6.073501,"eighty":-2.985517,"marketCap":302178474},{"date":"2023-10-20","current":-1.554179,"twenty":-28.433987,"median":-6.03151,"eighty":-2.97759,"marketCap":231120454},{"date":"2023-10-27","current":-1.441652,"twenty":-28.405392,"median":-5.928439,"eighty":-2.968495,"marketCap":214386654},{"date":"2023-10-31","current":-1.715631,"twenty":-28.376798,"median":-5.901894,"eighty":-2.952049,"marketCap":255129819},{"date":"2023-11-10","current":-1.722155,"twenty":-28.039355,"median":-5.858721,"eighty":-2.930485,"marketCap":256099895},{"date":"2023-11-17","current":-1.979826,"twenty":-28.035923,"median":-5.71039,"eighty":-2.91485,"marketCap":294417871},{"date":"2023-11-24","current":-2.02875,"twenty":-28.016616,"median":-5.633903,"eighty":-2.901331,"marketCap":301693436},{"date":"2023-11-30","current":-1.999395,"twenty":-28.001725,"median":-5.60396,"eighty":-2.893345,"marketCap":297328097},{"date":"2023-12-08","current":-2.788716,"twenty":-27.97095,"median":-5.565785,"eighty":-2.885679,"marketCap":414707216},{"date":"2023-12-15","current":-2.915921,"twenty":-27.861878,"median":-5.524342,"eighty":-2.86541,"marketCap":433623685},{"date":"2023-12-22","current":-3.000724,"twenty":-27.700134,"median":-5.423339,"eighty":-2.87393,"marketCap":446234665},{"date":"2023-12-29","current":-3.493234,"twenty":-27.650014,"median":-5.393661,"eighty":-2.880307,"marketCap":519475355},{"date":"2024-01-05","current":-3.212732,"twenty":-27.611556,"median":-5.386367,"eighty":-2.883495,"marketCap":477762114},{"date":"2024-01-12","current":-3.049649,"twenty":-27.40916,"median":-5.341757,"eighty":-2.885708,"marketCap":453510230},{"date":"2024-01-19","current":-2.671297,"twenty":-27.28668,"median":-5.318832,"eighty":-2.87393,"marketCap":397245859},{"date":"2024-01-26","current":-2.641942,"twenty":-27.21536,"median":-5.252758,"eighty":-2.857516,"marketCap":392880520},{"date":"2024-02-02","current":-2.65825,"twenty":-27.048361,"median":-5.24238,"eighty":-2.840818,"marketCap":395305709},{"date":"2024-02-09","current":-2.811548,"twenty":-26.929464,"median":-5.238007,"eighty":-2.82109,"marketCap":418102480},{"date":"2024-02-16","current":-3.345699,"twenty":-26.906442,"median":-5.1771,"eighty":-2.824233,"marketCap":481606727},{"date":"2024-02-23","current":-3.583465,"twenty":-26.854991,"median":-5.166441,"eighty":-2.82705,"marketCap":515832586},{"date":"2024-03-01","current":-4.194862,"twenty":-26.65795,"median":-5.128375,"eighty":-2.833277,"marketCap":603841937},{"date":"2024-03-08","current":-4.925141,"twenty":-26.590462,"median":-5.082199,"eighty":-2.839703,"marketCap":708964218},{"date":"2024-03-15","current":-4.768895,"twenty":-26.485011,"median":-5.040059,"eighty":-2.844164,"marketCap":686472939},{"date":"2024-03-22","current":-4.422437,"twenty":-26.463921,"median":-5.012652,"eighty":-2.84417,"marketCap":636600973},{"date":"2024-03-28","current":-4.964658,"twenty":-26.447049,"median":-4.974951,"eighty":-2.844195,"marketCap":714652544},{"date":"2024-04-05","current":-4.759789,"twenty":-26.415414,"median":-4.98173,"eighty":-2.85338,"marketCap":685162068},{"date":"2024-04-12","current":-5.844453,"twenty":-26.024738,"median":-4.983486,"eighty":-2.856191,"marketCap":845885164},{"date":"2024-04-19","current":-5.918098,"twenty":-25.993611,"median":-5.019289,"eighty":-2.859503,"marketCap":856544136},{"date":"2024-04-26","current":-5.06563,"twenty":-25.687803,"median":-5.038537,"eighty":-2.861707,"marketCap":733163817},{"date":"2024-05-03","current":-5.217271,"twenty":-25.638591,"median":-5.044024,"eighty":-2.862564,"marketCap":755111278},{"date":"2024-05-10","current":-5.717277,"twenty":-25.421383,"median":-5.067576,"eighty":-2.869679,"marketCap":827478580},{"date":"2024-05-17","current":-6.311545,"twenty":-25.131772,"median":-5.094876,"eighty":-2.880307,"marketCap":913488899},{"date":"2024-05-24","current":-6.217282,"twenty":-24.930653,"median":-5.129488,"eighty":-2.885621,"marketCap":899845883},{"date":"2024-05-31","current":-6.45499,"twenty":-24.90491,"median":-5.166441,"eighty":-2.885737,"marketCap":934250010},{"date":"2024-06-07","current":-6.426301,"twenty":-24.789066,"median":-5.1771,"eighty":-2.886406,"marketCap":930097788},{"date":"2024-06-14","current":-6.749893,"twenty":-24.658741,"median":-5.227517,"eighty":-2.886959,"marketCap":976932201},{"date":"2024-06-21","current":-9.471193,"twenty":-24.525617,"median":-5.23953,"eighty":-2.88779,"marketCap":1370794195},{"date":"2024-06-28","current":-9.279991,"twenty":-24.406952,"median":-5.243454,"eighty":-2.891219,"marketCap":1343120885},{"date":"2024-07-05","current":-8.657471,"twenty":-24.275811,"median":-5.252758,"eighty":-2.893345,"marketCap":1253021736},{"date":"2024-07-12","current":-9.298619,"twenty":-24.113906,"median":-5.316494,"eighty":-2.896315,"marketCap":1534290743},{"date":"2024-07-19","current":-8.111894,"twenty":-24.091681,"median":-5.328266,"eighty":-2.900864,"marketCap":1338478658},{"date":"2024-07-26","current":-8.564723,"twenty":-24.056995,"median":-5.352545,"eighty":-2.904334,"marketCap":1413196427},{"date":"2024-08-02","current":-8.111894,"twenty":-23.955631,"median":-5.386367,"eighty":-2.910683,"marketCap":1338478658},{"date":"2024-08-09","current":-8.127508,"twenty":-23.839786,"median":-5.406047,"eighty":-2.914325,"marketCap":1341055133},{"date":"2024-08-16","current":-8.697449,"twenty":-23.793127,"median":-5.428359,"eighty":-2.91485,"marketCap":1435096463},{"date":"2024-08-23","current":-9.376693,"twenty":-23.781864,"median":-5.533726,"eighty":-2.915278,"marketCap":1547173117},{"date":"2024-08-30","current":-9.83733,"twenty":-23.759339,"median":-5.565635,"eighty":-2.917676,"marketCap":1623179124},{"date":"2024-09-06","current":-9.107338,"twenty":-23.728769,"median":-5.569734,"eighty":-2.921619,"marketCap":1502728927},{"date":"2024-09-13","current":-9.681182,"twenty":-23.682109,"median":-5.60396,"eighty":-2.927583,"marketCap":1597414376},{"date":"2024-09-20","current":-10.001285,"twenty":-23.674065,"median":-5.635308,"eighty":-2.931486,"marketCap":1650232109},{"date":"2024-09-27","current":-8.998034,"twenty":-23.657975,"median":-5.711784,"eighty":-2.937079,"marketCap":1484693603},{"date":"2024-10-04","current":-8.666219,"twenty":-23.612925,"median":-5.729572,"eighty":-2.944401,"marketCap":1429943514},{"date":"2024-10-11","current":-9.458126,"twenty":-23.571092,"median":-5.783396,"eighty":-2.9489,"marketCap":1673861343},{"date":"2024-10-18","current":-10.026494,"twenty":-23.476164,"median":-5.844453,"eighty":-2.95149,"marketCap":1774448864},{"date":"2024-10-25","current":-10.514811,"twenty":-23.341012,"median":-5.883534,"eighty":-2.953956,"marketCap":1860869128},{"date":"2024-11-01","current":-9.794344,"twenty":-23.287917,"median":-5.918098,"eighty":-2.96168,"marketCap":1733363820},{"date":"2024-11-08","current":-10.943088,"twenty":-23.268609,"median":-5.970154,"eighty":-2.964208,"marketCap":1936663949},{"date":"2024-11-15","current":-9.173942,"twenty":-23.172073,"median":-6.032845,"eighty":-2.973677,"marketCap":1623567583},{"date":"2024-11-22","current":-8.825717,"twenty":-22.913032,"median":-6.100309,"eighty":-2.97759,"marketCap":1561940018},{"date":"2024-11-29","current":-8.849732,"twenty":-22.597678,"median":-6.159393,"eighty":-2.978904,"marketCap":1566190195},{"date":"2024-12-06","current":-8.55354,"twenty":-22.444828,"median":-6.217282,"eighty":-2.981965,"marketCap":1513771346},{"date":"2024-12-13","current":-8.113255,"twenty":-22.324157,"median":-6.269656,"eighty":-2.985517,"marketCap":1435851436},{"date":"2024-12-20","current":-7.937141,"twenty":-22.203486,"median":-6.336136,"eighty":-2.985517,"marketCap":1404683472},{"date":"2024-12-27","current":-7.648954,"twenty":-22.061899,"median":-6.385317,"eighty":-2.989919,"marketCap":1353681349},{"date":"2025-01-03","current":-7.88911,"twenty":-21.901004,"median":-6.45499,"eighty":-2.992398,"marketCap":1396183118},{"date":"2025-01-10","current":-7.300729,"twenty":-21.759416,"median":-6.532859,"eighty":-2.99628,"marketCap":1292053783},{"date":"2025-01-17","current":-7.660962,"twenty":-21.550253,"median":-6.579893,"eighty":-3.002029,"marketCap":1355806437},{"date":"2025-01-24","current":-7.977167,"twenty":-21.362006,"median":-6.618925,"eighty":-3.005245,"marketCap":1411767100},{"date":"2025-01-31","current":-7.727111,"twenty":-21.323392,"median":-6.711009,"eighty":-3.010282,"marketCap":1495729163},{"date":"2025-02-07","current":-7.401718,"twenty":-21.239726,"median":-6.73773,"eighty":-3.010327,"marketCap":1432743104},{"date":"2025-02-14","current":-6.895986,"twenty":-21.181804,"median":-6.749893,"eighty":-3.011561,"marketCap":1334849111},{"date":"2025-02-21","current":-6.613717,"twenty":-21.053088,"median":-6.741548,"eighty":-3.015785,"marketCap":1280210602},{"date":"2025-02-28","current":-6.05702,"twenty":-20.948506,"median":-6.711368,"eighty":-3.016547,"marketCap":1172451322},{"date":"2025-03-07","current":-5.433676,"twenty":-20.876104,"median":-6.692697,"eighty":-3.018537,"marketCap":1051791283},{"date":"2025-03-14","current":-5.327825,"twenty":-20.779567,"median":-6.657841,"eighty":-3.018537,"marketCap":1031301843},{"date":"2025-03-21","current":-5.092601,"twenty":-20.747388,"median":-6.609797,"eighty":-3.018704,"marketCap":985769752},{"date":"2025-03-28","current":-4.78518,"twenty":-20.66694,"median":-6.579893,"eighty":-3.021288,"marketCap":926262467},{"date":"2025-04-04","current":-3.816329,"twenty":-20.53018,"median":-6.536958,"eighty":-3.021288,"marketCap":738722905},{"date":"2025-04-11","current":-3.343506,"twenty":-20.425598,"median":-6.486683,"eighty":-3.021288,"marketCap":696793329},{"date":"2025-04-17","current":-3.745897,"twenty":-20.303318,"median":-6.440645,"eighty":-3.02349,"marketCap":780652482},{"date":"2025-04-25","current":-4.228767,"twenty":-20.034624,"median":-6.368923,"eighty":-3.026242,"marketCap":881283466},{"date":"2025-05-02","current":-4.122682,"twenty":-19.923607,"median":-6.295151,"eighty":-3.037798,"marketCap":859175144},{"date":"2025-05-09","current":-3.475198,"twenty":-19.730533,"median":-6.23765,"eighty":-3.047829,"marketCap":724238143},{"date":"2025-05-16","current":-3.497146,"twenty":-19.518152,"median":-6.182723,"eighty":-3.05237,"marketCap":728812278},{"date":"2025-05-23","current":-3.654445,"twenty":-19.341167,"median":-6.127117,"eighty":-3.05342,"marketCap":761593584},{"date":"2025-05-30","current":-3.892221,"twenty":-19.297726,"median":-6.073501,"eighty":-3.055108,"marketCap":811146720},{"date":"2025-06-06","current":-4.572629,"twenty":-19.262329,"median":-6.032177,"eighty":-3.056172,"marketCap":952944925},{"date":"2025-06-13","current":-4.375091,"twenty":-19.127177,"median":-5.936144,"eighty":-3.059063,"marketCap":911777704},{"date":"2025-06-20","current":-4.250715,"twenty":-18.74867,"median":-5.918098,"eighty":-3.067123,"marketCap":885857602},{"date":"2025-06-27","current":-4.331194,"twenty":-18.234918,"median":-5.89116,"eighty":-3.078991,"marketCap":902629432},{"date":"2025-07-03","current":-4.656765,"twenty":-18.104263,"median":-5.858721,"eighty":-3.083379,"marketCap":970479111},{"date":"2025-07-11","current":-4.672069,"twenty":-17.952663,"median":-5.803343,"eighty":-3.087591,"marketCap":968613327},{"date":"2025-07-18","current":-4.458194,"twenty":-17.932716,"median":-5.77315,"eighty":-3.099985,"marketCap":924272701},{"date":"2025-07-25","current":-4.251693,"twenty":-17.843949,"median":-5.711784,"eighty":-3.103287,"marketCap":881461063},{"date":"2025-08-01","current":-4.152131,"twenty":-17.367206,"median":-5.622749,"eighty":-3.103287,"marketCap":860819737},{"date":"2025-08-08","current":-3.713318,"twenty":-16.700963,"median":-5.577303,"eighty":-3.103287,"marketCap":769845004},{"date":"2025-08-15","current":-3.894005,"twenty":-16.297028,"median":-5.543294,"eighty":-3.103287,"marketCap":807305188},{"date":"2025-08-22","current":-3.558442,"twenty":-15.95493,"median":-5.455239,"eighty":-3.103287,"marketCap":737736275},{"date":"2025-08-29","current":-3.469942,"twenty":-15.700601,"median":-5.425849,"eighty":-3.103287,"marketCap":719388430},{"date":"2025-09-05","current":-3.363005,"twenty":-15.465716,"median":-5.386367,"eighty":-3.101636,"marketCap":697218117},{"date":"2025-09-12","current":-3.392505,"twenty":-15.356508,"median":-5.341757,"eighty":-3.103287,"marketCap":703334066},{"date":"2025-09-19","current":-3.307692,"twenty":-15.301653,"median":-5.32149,"eighty":-3.103287,"marketCap":685750714},{"date":"2025-09-26","current":-3.071692,"twenty":-15.258938,"median":-5.246197,"eighty":-3.084142,"marketCap":636823127},{"date":"2025-10-03","current":-3.348255,"twenty":-15.160097,"median":-5.233789,"eighty":-3.084142,"marketCap":694160143},{"date":"2025-10-10","current":-3.410969,"twenty":-15.019471,"median":-5.174055,"eighty":-3.084142,"marketCap":834954114},{"date":"2025-10-17","current":-3.150278,"twenty":-14.898109,"median":-5.119544,"eighty":-3.069205,"marketCap":771140863},{"date":"2025-10-24","current":-3.26649,"twenty":-14.719189,"median":-5.067576,"eighty":-3.069205,"marketCap":799587734},{"date":"2025-10-31","current":-4.014014,"twenty":-14.354151,"median":-5.035492,"eighty":-3.069205,"marketCap":982570312},{"date":"2025-11-07","current":-5.184725,"twenty":-13.952258,"median":-5.026629,"eighty":-3.069205,"marketCap":1269142822},{"date":"2025-11-14","current":-5.147454,"twenty":-13.599304,"median":-5.026629,"eighty":-3.069205,"marketCap":1260019591},{"date":"2025-11-21","current":-6.348389,"twenty":-13.33721,"median":-5.026629,"eighty":-3.069205,"marketCap":1553990372},{"date":"2025-11-28","current":-7.32156,"twenty":-13.032413,"median":-5.026629,"eighty":-3.069205,"marketCap":1792208074},{"date":"2025-12-05","current":-7.462359,"twenty":-12.948237,"median":-5.026629,"eighty":-3.069205,"marketCap":1826673614},{"date":"2025-12-12","current":-7.89718,"twenty":-12.801351,"median":-5.026629,"eighty":-3.069205,"marketCap":1933111311},{"date":"2025-12-19","current":-7.458218,"twenty":-12.695436,"median":-5.026629,"eighty":-3.069205,"marketCap":1825659922},{"date":"2025-12-26","current":-8.017274,"twenty":-12.624527,"median":-5.026629,"eighty":-3.069205,"marketCap":1962508389},{"date":"2026-01-02","current":-7.855769,"twenty":-12.501558,"median":-5.026629,"eighty":-3.069205,"marketCap":1922974387},{"date":"2026-01-09","current":-7.71497,"twenty":-12.184711,"median":-5.026629,"eighty":-3.069205,"marketCap":1888508848},{"date":"2026-01-16","current":-7.810216,"twenty":-11.288032,"median":-5.026629,"eighty":-3.069205,"marketCap":1911823772},{"date":"2026-01-23","current":-8.029697,"twenty":-10.881448,"median":-5.026629,"eighty":-3.069205,"marketCap":1965549466},{"date":"2026-01-30","current":-6.840464,"twenty":-10.6525,"median":-5.026629,"eighty":-3.069205,"marketCap":1809008581},{"date":"2026-02-06","current":-6.202695,"twenty":-10.261046,"median":-5.026629,"eighty":-3.069205,"marketCap":1640346041},{"date":"2026-02-13","current":-6.11714,"twenty":-10.076927,"median":-5.026629,"eighty":-3.069205,"marketCap":1617720578},{"date":"2026-02-20","current":-6.140473,"twenty":-10.009768,"median":-5.026629,"eighty":-3.069205,"marketCap":1623891159},{"date":"2026-02-27","current":-6.264916,"twenty":-9.904015,"median":-5.026629,"eighty":-3.069205,"marketCap":1656800923},{"date":"2026-03-06","current":-5.91881,"twenty":-9.787344,"median":-5.026629,"eighty":-3.069205,"marketCap":1565270642},{"date":"2026-03-13","current":-6.070474,"twenty":-9.667129,"median":-5.026629,"eighty":-3.069205,"marketCap":1605379417},{"date":"2026-03-20","current":-5.802145,"twenty":-9.535964,"median":-5.026629,"eighty":-3.069205,"marketCap":1534417739},{"date":"2026-03-27","current":-6.039364,"twenty":-9.389185,"median":-5.026629,"eighty":-3.069205,"marketCap":1597151976},{"date":"2026-04-02","current":-6.052863,"twenty":-9.318323,"median":-5.026629,"eighty":-3.069205,"marketCap":1600721985},{"date":"2026-04-10","current":-5.68718,"twenty":-9.263627,"median":-5.026629,"eighty":-3.069205,"marketCap":1679310403},{"date":"2026-04-17","current":-5.844768,"twenty":-9.17853,"median":-5.026629,"eighty":-3.069205,"marketCap":1725843018},{"date":"2026-04-24","current":-5.802744,"twenty":-9.11059,"median":-5.026629,"eighty":-3.069205,"marketCap":1713434321},{"date":"2026-05-01","current":-5.84827,"twenty":-9.003812,"median":-5.026629,"eighty":-3.069205,"marketCap":1726877077},{"date":"2026-05-08","current":-5.701187,"twenty":-8.896372,"median":-5.026629,"eighty":-3.069205,"marketCap":1683446635},{"date":"2026-05-15","current":-5.603133,"twenty":-8.823707,"median":-5.026629,"eighty":-3.069205,"marketCap":1654493008},{"date":"2026-05-22","current":-6.138932,"twenty":-8.738979,"median":-5.026629,"eighty":-3.069205,"marketCap":1812703901},{"date":"2026-05-29","current":-6.18796,"twenty":-8.66272,"median":-5.019289,"eighty":-3.067962,"marketCap":1827180715},{"date":"2026-06-05","current":-5.350992,"twenty":-8.62484,"median":-5.026629,"eighty":-3.069205,"marketCap":1580040822},{"date":"2026-06-12","current":-5.946325,"twenty":-8.579557,"median":-5.026629,"eighty":-3.069205,"marketCap":1755830704},{"date":"2026-06-18","current":-5.995352,"twenty":-8.55489,"median":-5.026629,"eighty":-3.069205,"marketCap":1770307518},{"date":"2026-06-26","current":-7.865397,"twenty":-8.489577,"median":-5.019289,"eighty":-3.067962,"marketCap":2322494559},{"date":"2026-07-02","current":-8.373181,"twenty":-8.442536,"median":-5.019289,"eighty":-3.067962,"marketCap":2472432988},{"date":"2026-07-10","current":-8.677763,"twenty":-8.413844,"median":-5.019289,"eighty":-3.067962,"marketCap":2562369753},{"date":"2026-07-17","current":-7.014022,"twenty":-8.368475,"median":-5.019289,"eighty":-3.067962,"marketCap":2394243426},{"date":"2026-07-24","current":-7.217724,"twenty":-8.305127,"median":-5.019289,"eighty":-3.067962,"marketCap":2463777154},{"date":"2026-07-31","current":-7.169078,"twenty":-8.251646,"median":-5.005311,"eighty":-3.066718,"marketCap":2447172085},{"date":"2026-08-07","current":-7.667691,"twenty":-8.126167,"median":-5.005311,"eighty":-3.066718,"marketCap":2617374045},{"date":"2026-08-14","current":-8.266635,"twenty":-8.111113,"median":-5.005311,"eighty":-3.066718,"marketCap":2821823960},{"date":"2026-08-21","current":-8.22407,"twenty":-8.111113,"median":-5.005311,"eighty":-3.066718,"marketCap":2807294525},{"date":"2026-08-28","current":-8.170864,"twenty":-8.106641,"median":-5.005311,"eighty":-3.066718,"marketCap":2789132730},{"date":"2026-09-04","current":-7.698094,"twenty":-8.059775,"median":-5.005311,"eighty":-3.066718,"marketCap":2627752213},{"date":"2026-09-11","current":-7.84707,"twenty":-8.020853,"median":-5.005311,"eighty":-3.066718,"marketCap":2678605238},{"date":"2026-09-18","current":-7.75282,"twenty":-8.00663,"median":-5.005311,"eighty":-3.066718,"marketCap":2646432916},{"date":"2026-09-25","current":-7.190361,"twenty":-7.986317,"median":-5.005311,"eighty":-3.066718,"marketCap":2454436802},{"date":"2026-10-02","current":-7.096111,"twenty":-7.953606,"median":-5.005311,"eighty":-3.066718,"marketCap":2422264481},{"date":"2026-10-07","current":-6.871127,"twenty":-7.93554,"median":-5.005311,"eighty":-3.066718,"marketCap":2345466035}],"updateTime":1791478665046},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRIX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673001724","title":"U.S. Earnings Preview: After Market Close Oct. 7","url":"https://stock-news.laohu8.com/highlight/detail?id=2673001724","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673001724?lang=en_us&edition=fundamental","pubTime":"2026-10-08 03:30","pubTimestamp":1791401400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the market closes.Levi Strauss & Co.'s third-quarter EPS is forecast at 36 cents.Applied Digital Corp.'s first-quarter EPS is forecast at a loss of 30 cents, compared with a loss of 7 cents in the prior-year period.Nurix Therapeutics Inc.'s third-quarter EPS is forecast at a loss of 60 cents, compared with a loss of $1.03 in the prior-year period.Richardson Electronics Ltd.'s first-quarter EPS is forecast at 9 cents, compared with 13 cents in the prior-year period.Resources Connection Inc.'s first-quarter EPS is forecast at a loss of 20 cents, compared with a loss of 7 cents in the prior-year period. Adjusted EPS is forecast at a loss of 17 cents.Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4123","BK4116","FDIG","DAPP","LU0757428866.USD","LEVI","RGP","APLD","BK4202","BK4023","LU1815336091.USD","BK4140","APLX","BK4609","APLZ","MNRS","BK4139","BK4608","IBLC","RELL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673060636","title":"Nurix Enrolls First Patient in Phase 1b/2 CLL Trial of BTK Degrader Bexobrutideg Plus Venetoclax","url":"https://stock-news.laohu8.com/highlight/detail?id=2673060636","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673060636?lang=en_us&edition=fundamental","pubTime":"2026-10-07 13:00","pubTimestamp":1791349216,"startTime":"0","endTime":"0","summary":"Nurix enrolls first patient in Phase 1b/2 CLL trial of BTK degrader bexobrutideg plus venetoclaxNurix enrolled the first patient in a Phase 1b/2 study testing BTK degrader bexobrutideg with venetoclax","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDLTbkV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","NRIX","LU0314104364.USD","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","BK4112","BK4139","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3F31.USD","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673060689","title":"Nurix Therapeutics Announces First Patient Enrolled in Phase 1B/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2673060689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673060689?lang=en_us&edition=fundamental","pubTime":"2026-10-07 13:00","pubTimestamp":1791349200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA47GW9Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704303","title":"Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704303","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704303?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198202,"startTime":"0","endTime":"0","summary":"Nurix, Gilead extend research term for oncology program by two years for $10 million feeNurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaborat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL7nTmpm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU0965509101.SGD","SG9999015945.SGD","LU2087621335.USD","TBXU","LU2468319806.SGD","GILD","LU0965509010.AUD","NRIX","SG9999015986.USD","BK4583","LU1057294990.SGD","LU1430594728.SGD","IE00BQXX3D17.EUR","LU1934455277.USD","TMED","SG9999014021.USD","BMED","IE0002270589.USD","IE00BQXX3F31.USD","BK4568","BK4585","LU0859254822.USD","LU2210150020.SGD","BK4112","LU0882574055.USD","IBBQ","LU1934455194.USD","BIB","IE00BN0W2W23.USD","BK4578","LU0289739699.SGD","SG9999015978.USD","LU0861579265.USD","IE00B3T34201.USD","NDAQ","IBB","LU0058720904.USD","LU0314104364.USD","BCDF","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1037948897.HKD","MEDI","BBH","BK4566","LU0965509283.SGD","LU0320765992.SGD","LU1839511570.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704306","title":"Nurix Extends Gilead Collaboration for Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704306","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704306?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198199,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Extends Gilead Collaboration For Oncology ProgramOct 5 (Reuters)-Nurix Therapeutics, Inc.NRIX.O:NURIX THERAPEUTICS ANNOUNCES SECOND RESEARCH TERM EXTENSION FOR ONCOLOGY PROGRAM UNDER COLLA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","LU1839511570.USD","TBXU","LU2468319806.SGD","IE00B7SZLL34.SGD","NRIX","IE00B19Z3B42.SGD","IBB","IE00BSNM7G36.USD","LU0058720904.USD","LU2324357040.USD","LU0320765992.SGD","LU1934455194.USD","BK4566","BBH","LU0882574055.USD","SG9999015952.SGD","LU0965508806.USD","LU0965509010.AUD","IE00B3T34201.USD","BK4550","IE00BKVL7J92.USD","LU1037948897.HKD","SG9999015978.USD","LU1585245621.USD","LU0109394709.USD","BK4139","BK4568","BMED","LU1023059063.AUD","LU2089984988.USD","LU1934455277.USD","LU2087621335.USD","IE0002270589.USD","LU0122379950.USD","LU1571399168.USD","IBBQ","LU0861579265.USD","LU0965509283.SGD","LU1066053197.SGD","LU1057294990.SGD","LU2357627491.SGD","LU1934455863.HKD","MEDI","LU0859254822.USD","TMED","SG9999015945.SGD","BIB","LU1674673691.USD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704828","title":"Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704828?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0058720904.USD","LU1037948897.HKD","BBH","LU0234570918.USD","IE00BKVL7J92.USD","TMED","LU0965509283.SGD","NRIX","BK4566","BK4550","LU1934455277.USD","LU1839511570.USD","LU0122379950.USD","LU0823416689.USD","SG9999015978.USD","LU1934455194.USD","LU2324357040.USD","LU2112291526.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4588","IE00B3T34201.USD","IBB","IE00B7SZLL34.SGD","BK4585","IE00B19Z3B42.SGD","BK4139","TBXU","IBBQ","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4532","LU0859254822.USD","MEDI","LU1585245621.USD","BK4568","BMED","LU1571399168.USD","BK4583","LU1778281490.HKD","LU0861579265.USD","LU0882574055.USD","LU0320765992.SGD","BK4578","LU1023059063.AUD","BIB","LU2089984988.USD","GILD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673701023","title":"Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2673701023","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673701023?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048487","title":"Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015986.USD","BIB","IE00B3T34201.USD","LU0889565916.HKD","LU1066053197.SGD","LU1934455863.HKD","BMED","LU1023059063.AUD","LU0122379950.USD","LU0823416689.USD","MEDI","LU0859254822.USD","LU0965509010.AUD","LU2468319806.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU2087621335.USD","LU1839511570.USD","NRIX","LU1037948541.HKD","IE00B19Z3B42.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD","TMED","BK4568","LU1057294990.SGD","LU1571399168.USD","BK4550","GILD","LU1778281490.HKD","LU1066051498.USD","LU0861579265.USD","LU0320765992.SGD","LU0234570918.USD","SG9999015945.SGD","LU1934455194.USD","IE00B19Z3581.USD","LU2089984988.USD","BBH","IBBQ","LU1674673428.USD","IE00BKVL7J92.USD","LU1037948897.HKD","LU0965509283.SGD","BK4566","IBB","TBXU","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048127","title":"Nurix - to Receive $10 Mln Research Term Extension Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048127?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","TMED","LU1037948897.HKD","SG9999015945.SGD","BK4566","IE0002270589.USD","LU1430594728.SGD","LU1934455194.USD","LU2087621335.USD","SG9999015952.SGD","LU0320765992.SGD","IBB","LU0965509101.SGD","LU1037948541.HKD","LU0861579265.USD","LU0965509283.SGD","MEDI","IE00BKVL7J92.USD","SG9999015986.USD","LU1023059063.AUD","LU2468319806.SGD","TBXU","LU2089984988.USD","BMED","LU1571399168.USD","IBBQ","BK4550","LU1934455863.HKD","LU0122379950.USD","LU1066051498.USD","BIB","IE00BSNM7G36.USD","LU1674673428.USD","LU0289739699.SGD","BK4568","IE00B19Z3581.USD","LU0234570918.USD","LU0965509010.AUD","LU1066053197.SGD","LU0823416689.USD","LU1839511570.USD","LU1778281490.HKD","LU0859254822.USD","BBH","IE00B3T34201.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","GILD","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021701","title":"Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU1778281490.HKD","LU1839511570.USD","BK4532","BK4568","LU0109394709.USD","LU1057294990.SGD","LU1934455277.USD","LU2087621335.USD","LU0889565916.HKD","BMED","LU0965509010.AUD","LU1571399168.USD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU0058720904.USD","SG9999015945.SGD","LU0861579265.USD","TMED","LU1066053197.SGD","LU1066051498.USD","IE00BSNM7G36.USD","BBH","SG9999015986.USD","IBB","BIB","IE0002270589.USD","IBBQ","LU1037948541.HKD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1037948897.HKD","TBXU","LU0882574055.USD","LU1934455194.USD","MEDI","BK4585","LU1430594728.SGD","LU0859254822.USD","LU0965509101.SGD","BK4578","SG9999015978.USD","NRIX","IE00B3T34201.USD","GILD","LU1061106388.HKD","BK4566","IE00B19Z3B42.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672974168","title":"Nurix Therapeutics Chief Legal Officer Christine Ring Reports Common Share Disposal Worth $134,160.79","url":"https://stock-news.laohu8.com/highlight/detail?id=2672974168","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672974168?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:21","pubTimestamp":1790976098,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics Chief Legal Officer Christine Ring reports common share disposal worth $134,160.79Christine Ring, Chief Legal Officer at Nurix Therapeutics, sold 5,786 common shares on Oct. 2, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL4qM4kv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nurix Therapeutics Chief Legal Officer Christine Ring Reports Common Share Disposal Worth $134,160.79","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671157692","title":"Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671157692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671157692?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:00","pubTimestamp":1790679601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA42HKSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BBT3K403.USD","BK4550","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU2596442595.SGD","NRIX","LU0985481810.HKD","SG9999002224.SGD","BK4534","BK4139","BK4599","LU0321505439.SGD","LU1894683264.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU1066053197.SGD","LU0170899867.USD","LU1057294990.SGD","SG9999013999.USD","BK4581","LU0225284248.USD","LU1066051498.USD","LU0456855351.SGD","BK4007","SGXZ57979304.SGD","IE00BLSP4452.SGD","BK4568","LU0122379950.USD","LU0225771236.USD","BK4533","LU1883839398.USD","IE0002270589.USD","IE00BLSP4239.USD","SG9999011175.SGD","IE00B3T34201.USD","BK4588","BK4585","LU0234572021.USD","LU0868494617.USD","LU0289739699.SGD","PFE","SG9999001176.USD","SG9999002232.USD","OZEM","LU0321505868.SGD","BK4592","LU1023059063.AUD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664619508","title":"Nurix CSO Gwenn Hansen Disposes of 1,452 Common Shares Worth $36,982.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2664619508","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664619508?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:19","pubTimestamp":1788297598,"startTime":"0","endTime":"0","summary":"Nurix CSO Gwenn Hansen disposes of 1,452 common shares worth $36,982.44Nurix Therapeutics Chief Scientific Officer Gwenn Hansen exercised employee stock options for 1,452 shares at USD 1.86 on Sept. 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL3dpqSy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nurix CSO Gwenn Hansen Disposes of 1,452 Common Shares Worth $36,982.44","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664562658","title":"Nurix Therapeutics to Participate in Upcoming September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664562658","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664562658?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354077/0/en/nurix-therapeutics-to-participate-in-upcoming-september-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097223","title":"Nurix Advances NX-5948 Combo Trial in B-Cell Cancers, Setting Up Key Catalyst for NRIX","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097223","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097223?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:31","pubTimestamp":1787934694,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics, Inc. ($NRIX) announced an update on their ongoing clinical study. The Phase 1b/2 study “An Open-label, Multicenter Phase 1b/2 S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nurix-advances-nx-5948-combo-trial-in-b-cell-cancers-setting-up-key-catalyst-for-nrix?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nurix-advances-nx-5948-combo-trial-in-b-cell-cancers-setting-up-key-catalyst-for-nrix?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175580","title":"BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175580","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175580?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:12","pubTimestamp":1787670744,"startTime":"0","endTime":"0","summary":"BeOne Medicines'  BTK degrader tacabrutideg presents a \"sizable opportunity\" in chronic spontaneous urticaria or CSU, RBC Capital Markets said in a Tuesday note.CSU is an inflammatory skin condition that can be a major market with peak sales estimates of about $3 billion, the brokerage said. BTK degraders have the potential to top BTK inhibitors in CSU, likely exceeding inhibitors in terms of potency and effect durability, RBC noted.Nurix Therapeutics  has reported that its BTK degrader bexobrutideg demonstrated greater potency in CSU compared with Novartis'  BTK inhibitor remibrutinib, and RBC sees tacabrutideg's overall efficacy profile as \"broadly comparable\" with bexobrutideg, according to the note.BeOne Medicines is planning to advance tacabrutideg to phase 2 studies in CSU, RBC noted.RBC has an outperform rating and $450 price target on BeOne Medicines.Price: 376.42, Change: +4.44, Percent Change: +1.19","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4526","IE00BFTCPJ56.SGD","LU0208291251.USD","MDCO","BK4585","BK4578","ONC","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","MEDX","NRIX","IE00BJT1NW94.SGD","BK4007","LU0070302665.USD","BK4532","PPH","LU0211331839.USD","BK4588","NVS","BK4139","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660863842","title":"Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660863842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660863842?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:00","pubTimestamp":1787223602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA4NZZHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456397","title":"Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456397","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456397?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:23","pubTimestamp":1787016212,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics (NRIX) has drawn investor attention after two key events. The company reported a new Phase 3 trial for its BTK degrader bexobrutideg and a separate US$10 million milestone payment from collaborator Sanofi.\nSee our latest analysis for Nurix Therapeutics.\nAgainst this backdrop, Nurix Therapeutics’ recent clinical milestones and collaboration progress have coincided with strong momentum, with a 30 day share price return of 17.52% and a 1 year total shareholder return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nrix/nurix-therapeutics/news/nurix-therapeutics-nrix-starts-phase-3-and-lands-sanofi-mile","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nrix/nurix-therapeutics/news/nurix-therapeutics-nrix-starts-phase-3-and-lands-sanofi-mile","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","SNYNF","NRIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659518428","title":"Nurix Therapeutics (NRIX) Is Up 6.0% After Milestone From Sanofi And Phase 3 Start With Roche","url":"https://stock-news.laohu8.com/highlight/detail?id=2659518428","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659518428?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:38","pubTimestamp":1786581503,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics recently reported earning a US$10 million milestone payment from Sanofi for advancing its oral STAT6 degrader into a Phase 1 trial, while also enrolling the first patient in a global Phase 3 study of its BTK degrader bexobrutideg in partnership with Roche for relapsed or refractory CLL/SLL.\nTogether, these updates highlight how Nurix’s DEL-AI protein degradation platform is now translating into late-stage clinical programs and tangible partnership revenues under its Sanofi...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nrix/nurix-therapeutics/news/nurix-therapeutics-nrix-is-up-60-after-milestone-from-sanofi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nrix/nurix-therapeutics/news/nurix-therapeutics-nrix-is-up-60-after-milestone-from-sanofi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NRIX","BK4139","SNYNF","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958987","title":"Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958987","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658958987?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:44","pubTimestamp":1786380254,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics'  STAT6 degrader NX-3911 is likely to receive increased recognition after advancing into clinical development under its collaboration with Sanofi , RBC Capital Markets said in a Monday research note.The investment firm said limited preclinical data suggest NX-3911 could be on relatively equal footing with Kymera Therapeutics'  KT-621, supporting higher value for Nurix when factoring in immunology and inflammation optionality across NX-3911, bex-deg and the rest of its pipeline.RBC expects NX-3911 to receive increased attention ahead of Kymera's STAT6 atopic dermatitis data expected by year-end, which could provide positive readthrough for Nurix's program. It noted that Sanofi is leading early clinical development of NX-3911, with a proof-of-concept dataset potentially available in the first half of 2027.The brokerage said bex-deg's chronic lymphocytic leukemia opportunity remains the core of its bullish thesis on Nurix, while the company also has optionality from its","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","TMED","BBH","KYMR","LU1934455194.USD","IBBQ","BK4585","LU0058720904.USD","LU1037948897.HKD","LU2112291526.USD","LU0109394709.USD","LU2324357040.USD","LU2089984988.USD","BK4532","BK4139","IE00B7SZLL34.SGD","LU1839511570.USD","NRIX","BK4588","SNY","IE00BKVL7J92.USD","LU1585245621.USD","GILD","IE0002270589.USD","SG9999015945.SGD","BIB","BMED","IE00BZ1G4Q59.USD","LU0823416689.USD","IBB","LU1571399168.USD","BK4007","LU1057294990.SGD","MEDI","LU1934455863.HKD","LU0882574055.USD","IE00B19Z3581.USD","BK4566","LU0320765992.SGD","LU1023059063.AUD","LU1430594728.SGD","LU1674673428.USD","IE00B3T34201.USD","LU1934455277.USD","SG9999015986.USD","LU0965509101.SGD","LU1066053197.SGD","BK4550","LU0965508806.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":117,"code":"91000000","status":"200"}]}}